Results 51 to 60 of about 148 (67)

Nutritional Counseling in Children with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: Analysis of Growth Response Parameters. [PDF]

Biomedicines
Budzulak J, Majewska KA, Kędzia A.
europepmc   +1 more source

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy. [PDF]

Clinicoecon Outcomes Res, 2019
Foo J, Maghnie M, Colao A, Vlachaki I, Colombo G.   +4 more
europepmc   +1 more source

Synthetic polypeptides using a biologic as a reference medicinal product - the European landscape of regulatory approvals. [PDF]

Front Med (Lausanne)
Klein K, Heisterberg J, Stolk P.
europepmc   +1 more source

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.

J Clin Endocrinol Metab, 2023
Backeljauw P, Blair JC, Ferran JM, Kelepouris N, Miller BS, Pietropoli A, Polak M, Sävendahl L, Verlinde F, Rohrer TR.   +9 more
europepmc   +1 more source

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution? [PDF]

Drug Des Devel Ther
Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD.   +3 more
europepmc   +1 more source

Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients. [PDF]

Med Devices (Auckl), 2016
Schnabel D, Partsch CJ, Houang M, Ehtisham S, Johnstone H, Zabransky M, Kiess W.   +6 more
europepmc   +1 more source

Evaluating biosimilars: safety, efficacy, and regulatory considerations in clinical studies. [PDF]

Int J Clin Pharm
Liu Y, Wang Y, Wang M, Zhai S, Hou C, Sun F, Jian L.   +6 more
europepmc   +1 more source